Product Name
CAS Number
Specification
TP
DMF
Status
Bimatoprost
155206-00-1
Enterprise Standard
Q2 2025
Latanoprost
130209-82-4
USP, EP
√
CEP
Quwo Prostaglandin
157283-68-6
USP, Enterprise Standard
√
Ropinirole
333963-40-9
Enterprise Standard
√
Dabrafenib Mesylate
1195768-06-9
Enterprise Standard
Q1 2025
Lenvatinib mesylate
857890-39-2
Enterprise Standard
√
Olaparib
763113-22-0
Enterprise Standard
Q1 2025
(Phosphate) Lorlatinib
941678-49-5 & 1092939-17-7
Enterprise Standard
Q4 2024
Abacillin
1231929-97-7
Q4 2024
Q2 2025
Acalabrutinib
1420477-60-6
Q3 2025
Q1 2026
Almonertinib
1256580-46-7
Q4 2024
Q2 2025
Apalutamide
956104-40-8
Q1 2025
Q3 2025
Apelis
1217486-61-7
Q3 2025
Q1 2026
Avapritinib
1703793-34-3
Q3 2025
Q1 2026
Baricitinib
1187594-09-7
Q1 2025
Q3 2025
Bimetinib
606143-89-9
Q4 2024
Q2 2025
Cabozantinib
849217-68-1
Q4 2024
Q2 2025
Carmatinib
1029712-80-8
Q3 2025
Q1 2026
Darolutamide
1297538-32-9
Q3 2025
Q1 2026
Deutetrabenazine
1609392-27-9
Q3 2025
Q1 2026